The Effects of Wheat Sprouts Supplements on the Key Health Indicators of the Patients With Breast Cancer After Chemotherapy

NCT04998994 | Completed

• 1 other identifier: 2018-172
• Study Type: observational
• Target: 60
• Locations: 1 country
• Sites: 1

Brief Summary

To explore the effects of wheat sprouts supplements on the key health indicators of the patients with breast cancer after chemotherapy, Maiji tablets, a wheat sprouts supplement, were used to treat 26 patients during the progress of chemotherapy and nutritional status, immune function, quality of life were measured and evaluated. Through data analysis, we found that Maiji tablets may improve the symptoms of appetite loss, nausea and vomiting, and fatigue in patients with breast cancer during chemotherapy. Meanwhile it may help patients maintain weight, keep appetite and improve the food intake.

Conditions

Nutritional Status, Immune Function, Quality of Life Uring the Progress of Chemotherapy

Outcome Measures

Primary Outcomes (3)

• quality of life

  Quality of life was measured by quality of life assessment form

  28 days

• weight

  the weight of patients

  28 days

• nutritional status

  nutritional status of patients

  28 days

Interventions

wheat sprouts supplement DIETARY_SUPPLEMENT

Maiji tablets, a wheat sprouts supplement, were used to treat 26 patients during the progress of chemotherapy

Eligibility Criteria

• Age: 18 Years - 65 Years
• Sex: female
• Healthy Volunteers: No
• Age Groups: Adult (18-64), Older Adult (65+)
• Sampling Method: Non-Probability Sample

Study Population

patients diagnosed with breast cancer, receiving chemotherapy for the first time

You may qualify if:

• \- patients diagnosed with breast cancer, receiving chemotherapy for the first time

You may not qualify if:

• \- Patients with severe liver or kidney disease or other infectious diseases

Sponsors & Collaborators

• Second Affiliated Hospital, School of Medicine, Zhejiang University: lead
• First Affiliated Hospital of Wenzhou Medical University: collaborator
• Quzhou Kecheng People's Hospital: collaborator
• Beijing Shijitan Hospital, Capital Medical University: collaborator
• Jinhua Municipal Central Hospital: collaborator
• Zhejiang Cancer Hospital: collaborator

Study Sites (1)

2nd Affiliated Hospital, School of Medicine, Zhejiang University

Hangzhou, Zhejiang, 310009, China

Location

Study Design

• Study Type: observational
• Observational Model: CASE ONLY
• Time Perspective: PROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: SPONSOR

Study Record Dates

• First Submitted: August 3, 2021
• First Posted: August 10, 2021
• Study Start: April 22, 2019
• Primary Completion: August 22, 2020
• Study Completion: October 1, 2020
• Last Updated: August 10, 2021

Record last verified: 2019-05

Data Sharing

• IPD Sharing: Will not share

Locations

CN (1)